OHSONG PHARM, a company specializing in the export of pharmaceuticals to Japan, was selected as a ‘Small Giant Company of Korea’ in 2020.
 

The Small Giant Company Support Project is designed to discover export SMEs with innovativeness and growth potential them as a “Export leading company”.
 

The Small Giant Company will receive the following benefits by 2023
▲export marketing services such as exhibitions, events, overseas sales support and PR videos
▲participation in domestic & international exhibitions, local buyer matching consultation seminar, overseas buyer domestic invitation meeting, overseas exhibition pre- and post-support, etc.
 

OHSONG PHARM has been selected as a ‘Jeju Local Small Giant Company’ in 2018 and has received steady support from Jeju. In addition, OHSONG PHARM established Brio pharma in 2017 (a subsidiary of japan) to enter the Japanese pharmaceutical market directly.
As a result, OHSONG PHARM could be selected as a 'Small Giant Company of Korea'.




 

OHSONG PHARM will expanding gradually its capabilities and scope with joint development contracts such as Whan-In Pharmaceutical and Daewoong Pharmaceutical as well as affiliate companies.
 

With this ‘Small Giant Company of Korea’, OHSONG PHARM will driving force for the Japanese market, and will become a leading company in the pharmaceutical and bio sectors in Korea.